IOLZX
Price
$27.98
Change
-$0.18 (-0.64%)
Updated
Sep 20 closing price
RRMGX
Price
$97.44
Change
-$0.69 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

IOLZX vs RRMGX

Header iconIOLZX vs RRMGX Comparison
Open Charts IOLZX vs RRMGXBanner chart's image
ICON Equity Institutional
Price$27.98
Change-$0.18 (-0.64%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth R
Price$97.44
Change-$0.69 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
IOLZX vs RRMGX Comparison Chart
Loading...
VS
IOLZX vs. RRMGX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IOLZX is a Buy and RRMGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RRMGX has more cash in the bank: 31.4B vs. IOLZX (50.6M). IOLZX pays higher dividends than RRMGX: IOLZX (0.64) vs RRMGX (0.00). IOLZX was incepted earlier than RRMGX: IOLZX (20 years) vs RRMGX (22 years). RRMGX is a more actively managed with annual turnover of: 21.70 vs. IOLZX (4.00). IOLZX has a lower initial minimum investment than RRMGX: IOLZX (1000) vs RRMGX (2500). RRMGX annual gain was more profitable for investors over the last year : 13.62 vs. IOLZX (3.54). RRMGX return over 5 years is better than : 9.23 vs. IOLZX (5.18).
IOLZXRRMGXIOLZX / RRMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years22 years-
Gain YTD1.0848.60513%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets50.6M31.4B0%
Annual Yield % from dividends0.640.00-
Returns for 1 year3.5413.6226%
Returns for 3 years-28.45-16.28175%
Returns for 5 years5.189.2356%
Returns for 10 years53.5633.74159%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OII26.020.16
+0.62%
Oceaneering International
COTY9.19-0.20
-2.13%
COTY
CLCO11.05-0.30
-2.64%
Cool Company Ltd
QLGN0.17-0.01
-3.55%
Qualigen Therapeutics
PRPH2.34-0.17
-6.77%
ProPhase Labs